Transcriptional regulation by DNA methylation

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Epigenetic alterations, including DNA methylation and histone modifications, play a crucial role in cancer development by altering gene expression.
• Unlike genetic mutations, epigenetic changes are potentially reversible, making them attractive targets for therapeutic intervention.
• Leukemias exhibit significant epigenetic dysregulation, highlighting the need for a deeper understanding of these mechanisms.

Purpose of the Study:

• To review current knowledge on epigenetic alterations in leukemias.
• To elucidate the molecular mechanisms underlying epigenetic changes in cancer.
• To highlight the interplay between genetic and epigenetic factors in leukemogenesis using CCAAT/enhancer-binding protein alpha (C/EBPα) as a model.

Main Methods:

• Literature review of epigenetic mechanisms in cancer.
• Summary of established knowledge on DNA methylation, histone modifications, and miRNA expression in leukemias.
• Case study analysis of C/EBPα epigenetic deregulation in myeloid progenitor cells.

Main Results:

• Epigenetic alterations synergize with genetic changes to drive cancer progression.
• Specific epigenetic deregulation of C/EBPα, a key granulocytic differentiation factor, exemplifies the cooperative action of genetic and epigenetic events in leukemogenesis.
• Altered DNA methylation, histone modifications, and miRNA expression are common in leukemia.

Conclusions:

• A comprehensive understanding of epigenetic mechanisms is essential for developing effective epigenetic therapies for leukemia.
• Targeting reversible epigenetic alterations offers a promising therapeutic avenue.
• The study of specific genes like C/EBPα provides insights into the complex interplay of genetic and epigenetic factors in leukemia development.